Invacare Profit Margin 2006-2018 | IVC

Current and historical gross margin, operating margin and net profit margin for Invacare (IVC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Invacare net profit margin as of December 31, 2018 is -4.52%.
Invacare Annual Profit Margins
Invacare Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.320B $0.972B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.819B 22.19
McKesson (MCK) United States $26.004B 10.12
Align Technology (ALGN) United States $20.393B 51.93
AmerisourceBergen (ABC) United States $18.293B 13.27
Cardinal Health (CAH) United States $16.534B 11.14
Laboratory Of America Holdings (LH) United States $15.152B 13.63
Cooper (COO) United States $13.769B 24.23
DENTSPLY SIRONA (XRAY) United States $9.699B 19.37
Henry Schein (HSIC) United States $9.511B 15.64
West Pharmaceutical Services (WST) United States $7.549B 36.27
Merit Medical Systems (MMSI) United States $3.268B 38.70
Patterson (PDCO) United States $2.196B 16.76
CONMED (CNMD) United States $2.024B 33.00
STAAR Surgical (STAA) United States $1.607B 165.54
Atrion (ATRI) United States $1.473B 42.11
Antares Pharma (ATRS) United States $0.504B 0.00
Lifevantage (LFVN) United States $0.227B 30.54
Pro-Dex (PDEX) United States $0.065B 29.51
Endologix (ELGX) United States $0.056B 0.00
Biolase (BIOL) United States $0.044B 0.00
Aceto (ACET) United States $0.034B 0.00